Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $64.5B
1-Year Est. Return 42.74%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+42.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$64.5B
AUM Growth
-$11.3B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,923
New
Increased
Reduced
Closed

Top Buys

1 +$616M
2 +$481M
3 +$416M
4
TSLA icon
Tesla
TSLA
+$416M
5
PG icon
Procter & Gamble
PG
+$322M

Top Sells

1 +$885M
2 +$660M
3 +$463M
4
APP icon
Applovin
APP
+$430M
5
META icon
Meta Platforms (Facebook)
META
+$354M

Sector Composition

1 Technology 20.85%
2 Healthcare 15.77%
3 Consumer Discretionary 13.88%
4 Industrials 9.93%
5 Financials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRBU icon
1701
Caribou Biosciences
CRBU
$188M
$2.61M ﹤0.01%
1,639,857
+859,436
FBLA
1702
FB Bancorp
FBLA
$190M
$2.61M ﹤0.01%
202,900
+159,700
TRDA icon
1703
Entrada Therapeutics
TRDA
$531M
$2.6M ﹤0.01%
252,635
-341,665
NMRA icon
1704
Neumora Therapeutics
NMRA
$386M
$2.59M ﹤0.01%
1,445,902
+281,926
ZTO icon
1705
ZTO Express
ZTO
$19B
$2.58M ﹤0.01%
123,700
-196,300
EEMV icon
1706
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.18B
$2.58M ﹤0.01%
40,319
+28,319
TAYD icon
1707
Taylor Devices
TAYD
$159M
$2.58M ﹤0.01%
44,162
+700
ELA icon
1708
Envela
ELA
$439M
$2.57M ﹤0.01%
192,104
-6,600
TOI icon
1709
The Oncology Institute
TOI
$317M
$2.57M ﹤0.01%
721,900
-28,600
PDBC icon
1710
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.5B
$2.57M ﹤0.01%
+193,858
OCFC icon
1711
OceanFirst Financial
OCFC
$1.06B
$2.57M ﹤0.01%
143,043
-21,300
VRTS icon
1712
Virtus Investment Partners
VRTS
$860M
$2.57M ﹤0.01%
15,729
+13,200
NBTB icon
1713
NBT Bancorp
NBTB
$2.28B
$2.56M ﹤0.01%
61,773
-7,600
WFG icon
1714
West Fraser Timber
WFG
$5.08B
$2.56M ﹤0.01%
41,900
+14,000
DCBO
1715
Docebo
DCBO
$449M
$2.55M ﹤0.01%
115,031
-14,102
RPTX
1716
DELISTED
Repare Therapeutics
RPTX
$2.55M ﹤0.01%
981,360
+257,200
MG icon
1717
Mistras Group
MG
$490M
$2.55M ﹤0.01%
201,600
+20,800
HUM icon
1718
Humana
HUM
$21.9B
$2.55M ﹤0.01%
9,953
-426,847
IVVD icon
1719
Invivyd
IVVD
$367M
$2.54M ﹤0.01%
+1,026,620
EVTL icon
1720
Vertical Aerospace
EVTL
$236M
$2.53M ﹤0.01%
474,400
+27,200
CURB
1721
Curbline Properties
CURB
$2.75B
$2.53M ﹤0.01%
+108,817
ABX
1722
Abacus Global Management
ABX
$773M
$2.52M ﹤0.01%
295,000
-166,900
CION icon
1723
CION Investment
CION
$357M
$2.52M ﹤0.01%
260,800
-46,700
MITT
1724
TPG Mortgage Investment Trust
MITT
$238M
$2.52M ﹤0.01%
295,741
-50,600
TDC icon
1725
Teradata
TDC
$2.45B
$2.52M ﹤0.01%
82,632
-705,963